SCHEMBL2492230

SCHEMBL2492230

[CH2]c1ccc(-c2ccccc2)c(-c2ccccc2)c1CCC

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCGR P47871 4/20 0.38
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
USP7 Q93009 3/20 0.34
DHFR P00374 2/20 0.34
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
TSHR P16473 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HEXA P06865 1/20 0.33
HEXB P07686 1/20 0.33
HTT P42858 1/20 0.32
DCTPP1 Q9H773 1/20 0.32
PPARG P37231 1/20 0.31
ADRB2 P07550 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2492131 0.90 GCGR (0.45) GCGRDHFRTSHRDCTPP1
SCHEMBL2491463 0.86 GCGR (0.44) GCGRKDM4EUSP7DHFRHEXA
SCHEMBL2201210 0.79 ESR2 (0.43) GCGRKDM4EALDH1A1GAAHPGD
Phenol SCHEMBL11324277 0.76 USP7 (0.43) GCGRALDH1A1HPGDUSP7HSD17B10
SCHEMBL2492089 0.75 SMN1; SMN2 (0.38) GCGRDHFRADORA2AADORA1HEXA
SCHEMBL28769956 0.74 USP7 (0.47) GCGRKDM4EUSP7DHFRHEXA
SCHEMBL28130655 0.73 GCGR (0.35) GCGRKDM4EALDH1A1GAAHPGD
SCHEMBL27975915 0.73 ALDH1A1 (0.47) GCGRKDM4EALDH1A1GAAHPGD
SCHEMBL4870784 0.73 LMNA (0.39) ALDH1A1HPGDHSD17B10HTT
SCHEMBL2491574 0.72 MGAM (0.38) GAAADORA3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2380567-B1 MELANIN PRODUCTION INHIBITOR POLA CHEM IND INC (JP) 2019-01-16 EP disclosed
EP-3009123-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2016-04-20 EP disclosed
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2015-11-19 US disclosed
EP-2845587-A2 Melanin production inhibitor Pola Chemical Industries Inc. (JP) 2015-03-11 EP disclosed
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2014-12-11 US disclosed
US-8846012-B2 Melanin production inhibitor POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-30 US disclosed
EP-2380567-A1 MELANIN PRODUCTION INHIBITOR Pola Chemical Industries Inc. (JP) 2011-10-26 EP disclosed
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110243865-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, TH GCGR 885/4885KDM4E 2772/4885ALDH1A1 1292/4885
US-20150328107-A1 MELANIN PRODUCTION INHIBITOR TYR, MC1R, F12 GCGR 808/4885KDM4E 3096/4885ALDH1A1 1031/4885
US-20140363389-A1 MELANIN PRODUCTION INHIBITOR TYR, F12, MC1R GCGR 839/4885KDM4E 3125/4885ALDH1A1 1187/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.